BEAM Q4 2019 Earnings — Beam Therapeutics Inc. Revenue & Financial Results | Market Cap Arena

BEAMBeam Therapeutics Inc.

$3B

Q4 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$6,000

Gross Profit

-$20M-336850.0% margin

Operating Income

-$26M-439516.7% margin

Net Income

-$28M-464166.7% margin

EPS (Diluted)

$-0.91

QoQ Revenue Growth

+0.0%

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$20M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$156M

Total Liabilities

$55M

Stockholders' Equity

$101M

Cash & Equivalents

$37M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6,000	$0	—
Gross Profit	-$20M	-$13M	-50.2%
Operating Income	-$26M	-$14M	-94.4%
Net Income	-$28M	-$25M	-10.5%